Length of remdesivir treatment in patients with severe COVID-19

被引:2
|
作者
Ippolito, Mariachiara [1 ]
Cortegiani, Andrea [1 ,2 ]
机构
[1] Univ Palermo, Dept Surg Oncol & Oral Sci DiChirOnS, Palermo, Italy
[2] Policlin Paolo Giaccone, Dept Anesthesia Intens Care & Emergency, Palermo, Italy
关键词
D O I
10.1183/20734735.0276-2020
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
[No abstract available]
引用
收藏
页数:3
相关论文
共 50 条
  • [31] Compassionate Use of Remdesivir in Children With Severe COVID-19
    Goldman, David L.
    Aldrich, Margaret L.
    Hagmann, Stefan H. F.
    Bamford, Alasdair
    Camacho-Gonzalez, Andres
    Lapadula, Giuseppe
    Lee, Philip
    Bonfanti, Paolo
    Carter, Christoph C.
    Zhao, Yang
    Telep, Laura
    Pikora, Cheryl
    Naik, Sarjita
    Marshall, Neal
    Katsarolis, Ioannis
    Das, Moupali
    DeZure, Adam
    Desai, Polly
    Cao, Huyen
    Chokkalingam, Anand P.
    Osinusi, Anu
    Brainard, Diana M.
    Mendez-Echevarria, Ana
    [J]. PEDIATRICS, 2021, 147 (05)
  • [32] Remdesivir for severe covid-19: a clinical practice guideline
    Rochwerg, Bram
    Agarwal, Arnav
    Zeng, Linan
    Leo, Yee-Sin
    Appiah, John Adabie
    Agoritsas, Thomas
    Bartoszko, Jessica
    Brignardello-Petersen, Romina
    Ergan, Begum
    Ge, Long
    Geduld, Heike
    Gershengorn, Hayley B.
    Manai, Hela
    Huang, Minhua
    Lamontagne, Francois
    Kanda, Seema
    Kawano-Dourado, Leticia
    Kurian, Linda
    Kwizera, Arthur
    Murthy, Srinivas
    Qadir, Nida
    Siemieniuk, Reed
    Silvestre, Maria Asuncion
    Vandvik, Per Olav
    Ye, Zhikang
    Zeraatkar, Dena
    Guyatt, Gordon
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2020, 370
  • [33] Use of remdesivir in the presence of elevated LFTs for the treatment of severe COVID-19 infection
    Sabers, Andrew J.
    Williams, Amber L.
    Farley, T. Michael
    [J]. BMJ CASE REPORTS, 2020, 13 (10)
  • [34] Views and insights into the remdesivir study for the treatment of severe pediatric COVID-19 cases
    Cao, Taige
    [J]. HEALTH SCIENCE REPORTS, 2024, 7 (07)
  • [35] Is It Time to Revisit Remdesivir Use for Severe COVID-19?
    Taggarsi, Dipali Anand
    [J]. INDIAN JOURNAL OF CRITICAL CARE MEDICINE, 2022, 26 (09) : 983 - 984
  • [36] Remdesivir in moderate to severe COVID-19: A matter of time?
    Bonazzetti, Cecilia
    Giacomelli, Andrea
    Pavia, Martina
    Fusetti, Chiara
    Gerbi, Martina
    Petri, Francesco
    Poloni, Andrea
    Oreni, Letizia
    Ridolfo, Anna Lisa
    Antinori, Spinello
    [J]. PHARMACOLOGICAL RESEARCH, 2021, 170
  • [37] Remdesivir for the treatment of COVID-19: a Cochrane review
    Ansems, Kelly
    Grundeis, Felicitas
    Dahms, Karolina
    Mikolajewska, Agata
    Thieme, Volker
    Piechotta, Vanessa
    Metzendorf, Maria-Inti
    Stegemann, Miriam
    Benstoem, Carina
    Fichtner, Falk
    [J]. EMERGENCIAS, 2023, 35 (06): : 465 - 467
  • [38] Remdesivir: treatment of COVID-19 in special populations
    Molaei, Emad
    Molaei, Ali
    Hayes, A. Wallace
    Karimi, Gholamreza
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2024, 397 (06) : 3829 - 3855
  • [39] Remdesivir for the Treatment of COVID-19: A Narrative Review
    Godwin, Patrick O.
    Polsonetti, Bryan
    Caron, Michael F.
    Oppelt, Thomas F.
    [J]. INFECTIOUS DISEASES AND THERAPY, 2024, 13 (01) : 1 - 19
  • [40] A Potential Antiviral Treatment for COVID-19 Remdesivir
    O'Malley, Patricia Anne
    [J]. CLINICAL NURSE SPECIALIST, 2020, 34 (06) : 257 - 260